Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Nutriband Inc.

Nutriband Co-Founder Gareth Sheridan Returns as CEO
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. to Present at the MicroCap Rodeo Conference
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband CEO Publishes Letter to Shareholders
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Signs Partnership Agreement with Charlotte FC
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Issues Letter to Shareholders
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.